Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 3/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 3/20 | 0.43 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.43 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | STAT6 | P42226 | 1/20 | 0.43 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7037484 | 0.97 | LMNA (0.41) | LMNAGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL9951776 | 0.95 | — | — | |
| SCHEMBL20198526 | 0.89 | LMNA (0.39) | LMNAGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL21656690 | 0.89 | LMNA (0.39) | LMNAGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL31265072 | 0.88 | — | — | |
| SCHEMBL301312 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL23877623 | 0.79 | — | — | |
| SCHEMBL20663016 | 0.77 | SLC22A2 (0.30) | LMNAGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL21309681 | 0.74 | GRIN2D (0.37) | LMNAGRIN1GRIN2AGRIN2DGRIN3B | |
| SCHEMBL25001468 | 0.74 | GRIN2D (0.37) | LMNAGRIN1GRIN2AGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050256-A | Polymerizable composition | 华为技术有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-20070232838-A1 | Alcohol Oxidation Catalyst and Method of Synthesizing the Same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-10-04 | — | — | US | claimed |
| EP-1775296-A1 | ALCOHOL OXIDATION CATALYST AND METHOD OF SYNTHESIZING THE SAME | TOHOKU UNIVERSITY (JP) | 2007-04-18 | — | — | EP | claimed |
| EP-1847545-B1 | SUBSTITUTED ETHYNYL GOLD-NITROGENATED HETEROCYCLIC CARBENE COMPLEX AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | UBE INDUSTRIES (JP) | 2013-03-06 | — | — | EP | disclosed |
| EP-1847545-A1 | SUBSTITUTED ETHYNYL GOLD-NITROGENATED HETEROCYCLIC CARBENE COMPLEX AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | Ube Industries, Ltd. (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20070232838-A1 | Alcohol Oxidation Catalyst and Method of Synthesizing the Same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-10-04 | — | — | US | disclosed |
| EP-1775296-A1 | ALCOHOL OXIDATION CATALYST AND METHOD OF SYNTHESIZING THE SAME | TOHOKU UNIVERSITY (JP) | 2007-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232838-A1 | Alcohol Oxidation Catalyst and Method of Synthesizing the Same | ADH1A, ADH1C, AOC3 | LMNA 2402/4885GRIN1 1048/4885GRIN2A 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.